BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22229571)

  • 1. Progress in gene and cell therapy for cystic fibrosis lung disease.
    Griesenbach U; Alton EW
    Curr Pharm Des; 2012; 18(5):642-62. PubMed ID: 22229571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and future directions of gene and cell therapy for cystic fibrosis.
    Griesenbach U; Alton EW
    BioDrugs; 2011 Apr; 25(2):77-88. PubMed ID: 21443272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is gene therapy in cystic fibrosis a realistic expectation?
    McElvaney NG
    Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral approach toward gene therapy of cystic fibrosis lung disease.
    Bragonzi A; Conese M
    Curr Gene Ther; 2002 Sep; 2(3):295-305. PubMed ID: 12189717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.
    Tang Y; Yan Z; Engelhardt JF
    Hum Gene Ther; 2020 May; 31(9-10):524-537. PubMed ID: 32138545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward cystic fibrosis gene therapy.
    Wagner JA; Gardner P
    Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
    Marquez Loza LI; Yuen EC; McCray PB
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
    Copreni E; Penzo M; Carrabino S; Conese M
    Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in cystic fibrosis.
    Armstrong DK; Cunningham S; Davies JC; Alton EW
    Arch Dis Child; 2014 May; 99(5):465-8. PubMed ID: 24464978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging gene therapies for cystic fibrosis.
    Miah KM; Hyde SC; Gill DR
    Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the way to gene therapy in cystic fibrosis].
    Norek A; Bal J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on gene therapy for cystic fibrosis airway disease.
    Bigger B; Coutelle C
    BioDrugs; 2001; 15(9):615-34. PubMed ID: 11580305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on gene therapy for cystic fibrosis.
    Griesenbach U; Geddes DM; Alton EW
    Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving forward: cystic fibrosis gene therapy.
    Griesenbach U; Alton EW
    Hum Mol Genet; 2013 Oct; 22(R1):R52-8. PubMed ID: 23918661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.